Telix Pharmaceuticals (TLX) Prepaid Assets (2023 - 2025)

Telix Pharmaceuticals (TLX) posted quarterly Prepaid Assets of $16.1 million for Q4 2025, up 7.89% year-on-year from $14.9 million in Q4 2024, and up 7.89% on a QoQ basis from $14.9 million in Q4 2024.

Telix Pharmaceuticals (TLX) Prepaid Assets (2023 - 2025) Analysis & Trends

Telix Pharmaceuticals (TLX) has reported Prepaid Assets for 3 consecutive years, with $16.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Prepaid Assets rose 7.89% year-over-year to $16.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.1 million (up 7.89% YoY) and the FY2025 annual result came in at $16.1 million, up 17.8% from the prior year.
  • Prepaid Assets advanced to $16.1 million in Q4 2025 per TLX's latest filing, from $14.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for TLX reached as high as $16.1 million in Q4 2025 and fell as low as $13.8 million in Q4 2023.
  • A 3-year average of $14.9 million and a median of $14.9 million in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets grew 8.15% — and 2025, when it rose 7.89%.
  • Year by year, Prepaid Assets stood at $13.8 million in 2023, then advanced by 8.15% to $14.9 million in 2024, then increased by 7.89% to $16.1 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $16.1 million, $14.9 million, and $13.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Telix Pharmaceuticals 3.55 Bn 3.41 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 16.09 Mn
Dec 31, 2024 14.91 Mn
Dec 31, 2023 13.79 Mn